# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-14-065719
Filing Date
2014-11-06
Accepted
2014-11-06 16:52:19
Documents
19
Period of Report
2014-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 10-Q | v392163_10q.htm | 10-Q | 520063
2 | EXHIBIT 10.1 | v392163_ex10-1.htm | EX-10.1 | 5011
3 | EXHIBIT 31.1 | v392163_ex31-1.htm | EX-31.1 | 8642
4 | EXHIBIT 31.2 | v392163_ex31-2.htm | EX-31.2 | 8209
5 | EXHIBIT 32.1 | v392163_ex32-1.htm | EX-32.1 | 4086
6 | EXHIBIT 32.2 | v392163_ex32-2.htm | EX-32.2 | 3726
13 | GRAPHIC | image_001.jpg | GRAPHIC | 271338
14 | GRAPHIC | image_002.jpg | GRAPHIC | 186492
15 | GRAPHIC | image_003.jpg | GRAPHIC | 157040
16 | GRAPHIC | image_004.jpg | GRAPHIC | 154964
17 | GRAPHIC | image_005.jpg | GRAPHIC | 301122
18 | GRAPHIC | image_006.jpg | GRAPHIC | 267859
19 | GRAPHIC | image_007.jpg | GRAPHIC | 147701
| Complete submission text file | 0001144204-14-065719.txt |  | 7774892

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL INSTANCE DOCUMENT | nvax-20140930.xml | EX-101.INS | 810922
8 | XBRL TAXONOMY EXTENSION SCHEMA | nvax-20140930.xsd | EX-101.SCH | 39031
9 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | nvax-20140930_cal.xml | EX-101.CAL | 58914
10 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | nvax-20140930_def.xml | EX-101.DEF | 185877
11 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | nvax-20140930_lab.xml | EX-101.LAB | 766707
12 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | nvax-20140930_pre.xml | EX-101.PRE | 352081

Mailing Address 20 FIRSTFIELD ROAD GAITHERSBURG MD 20878
Business Address 20 FIRSTFIELD ROAD GAITHERSBURG MD 20878 240-268-2000
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

EIN.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26770 | Film No.: 141201506
SIC: 2836 Biological Products, (No Diagnostic Substances)